H

Healios K.K.

26 employees

Healios develops treatments for retinal diseases and age-related macular degeneration (AMD) using cell technology.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Stem cell
バイオベンチャー
再生医薬品
マザーズ
再生医療
iPS
MultiStem
Medical
Health Care

Date founded

2011

Funding rounds raised

Total raised

$31M

from 5 investors over 5 rounds

H

Healios K.K. raised $31M on October 8, 2013

Investors: Dainippon Sumitomo Pharma, SNBL USA and Dogan, Inc.

H

Healios K.K. raised $214K on October 19, 2012

Investors: ｉＰＳアカデミアジャパン株式会社 and （株）アステム

FAQ